Element Solutions Well-Positioned For Growth In 5G, Semiconductors, And EV Market: Analyst
BMO Capital Markets analyst Bhavesh Lodaya initiated coverage of Element Solutions Inc (NYSE: ESI) with an Outperform rating
This Analyst Is Bullish On Entegris As A Value Compounder With Strong Growth Prospects: Initiates With Outperform Rating
BMO Capital Markets analyst Bhavesh Lodaya initiated coverage of Entegris Inc (NASDAQ: ENTG) at an
Benzinga’s Top Ratings Upgrades, Downgrades For June 20, 2023
Upgrades Tudor Pickering upgraded the previous rating for EQT Corp (NYSE:EQT) from Hold to Buy. EQT earned $1.70…
Piper Sandler Initiates Coverage Of PCB Bancorp, Anticipates Higher Buybacks Despite Marginal Pressures
Piper Sandler & Co analyst Matthew T.
Benzinga’s Top Ratings Upgrades, Downgrades For June 16, 2023
Upgrades According to B of A Securities, the prior rating for West Pharmaceutical Services Inc (NYSE:WST) was changed…
Mersana’s UpRi Shows Potential in Ovarian Cancer; Analyst Initiates Coverage with Buy Rating
Guggenheim Partners has initiated coverage on Mersana Therapeutics Inc (NASDAQ: MRSN) with a Buy rating
Analyst Anticipates Tecnoglass Expansion In Vinyl Windows Market, Predicts $180M FCF In 2023
Stifel Research analyst Stanley S.
Benzinga’s Top Ratings Upgrades, Downgrades For June 15, 2023
Upgrades For OGE Energy Corp (NYSE:OGE), Ladenburg Thalmann upgraded the previous rating of Neutral to Buy. In the…
EyePoint’s EYP-1901 Tipped to Transform Wet AMD Market, Analyst Predicts Potential $870M Sales by 2035
JonesResearch has initiated coverage of ophthalmic biopharmaceutical company EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) with a Buy rating and
Investor Opportunities Ahead of Clinical Updates, Says Analyst Initiating Coverage on Ambrx Biopharma with ‘Buy’ Rating
B Riley Securities has initiated Ambrx Biopharma Inc (NASDAQ: AMAM) with a Buy rating and a